Effect of Sira Vedha on Non Alcoholic Fatty Liver Diseases
Phase 2
- Conditions
- Health Condition 1: R688- Other general symptoms and signs
- Registration Number
- CTRI/2020/04/024783
- Lead Sponsor
- Datta Meghe Institute of Medical Sciences Deemed to be University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Inclusion criteria for the study include a) All patients irrespective of sex having age between 20 to 50 years with Non-Alcoholic Fatty Liver Disease (Grade I & Grade II fatty liver), b) able to give informed consent and willingness to participate in follow-up.
Exclusion Criteria
Exclusion criteria for the study include- patients with carcinoma of liver, liver cirrhosis, HIV positive, HBsAg positive, terminal illness, pregnant and lactating lady, accidental cases, all types of anemias, Hemophilia, Thalassemia, case of poisoning, alcoholic liver diseases, eczema over Rt. elbow joint, skin diseases/ allergy, injury at right elbow joint.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary objective is to study the effect of Sira Vedha at Right Elbow Joint in the management of Non-Alcoholic Fatty Liver Diseases as an adjuvant therapy.Timepoint: Baseline 30th day 60th day
- Secondary Outcome Measures
Name Time Method a) To study the effect of Sira Vedha at Right Elbow Joint on Liver Function, lipid profile, CBC count in Non-Alcoholic Fatty Liver Diseases in study group, b) To study the effect of Sira Vedha at Right Elbow Joint on Liver Function, lipid profile, CBC count in Non-Alcoholic Fatty Liver Diseases in control group, c) To compare the effect of Sira Vedha at Right Elbow Joint by evaluating the values of Liver Function, lipid profile, CBC count in study and control group.Timepoint: Baseline 30th day 60th day